Edwards Lifesciences Corporation (ETR:EWL)
Germany
· Delayed Price · Currency is EUR 69.99
-2.51 (-3.46%)
At close: Mar 6, 2026
Edwards Lifesciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1,074 | 4,175 | 1,402 | 1,522 | 1,503 | Upgrade
|
| Depreciation & Amortization | 156.6 | 143.2 | 122 | 139.6 | 134.8 | Upgrade
|
| Loss (Gain) From Sale of Assets | -33.9 | -3,348 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 40 | - | - | 55.1 | 4 | Upgrade
|
| Loss (Gain) From Sale of Investments | 146.9 | -55 | - | 51.5 | -36.8 | Upgrade
|
| Stock-Based Compensation | 158.1 | 162.3 | 139.4 | 126.8 | 109.3 | Upgrade
|
| Other Operating Activities | -100.6 | -287.3 | -264.6 | -255.3 | -127.6 | Upgrade
|
| Change in Accounts Receivable | -23 | 121.2 | -141.2 | -84.1 | -91.1 | Upgrade
|
| Change in Inventory | 50.7 | -256.1 | -289 | -213.4 | 19 | Upgrade
|
| Change in Accounts Payable | 395.1 | 89.5 | 146 | -21.4 | 195.2 | Upgrade
|
| Change in Income Taxes | -141.8 | -186.7 | -5.8 | -5.6 | 62 | Upgrade
|
| Change in Other Net Operating Assets | -126.4 | -27.2 | -236.3 | -96.9 | -39.8 | Upgrade
|
| Operating Cash Flow | 1,595 | 542.3 | 895.8 | 1,218 | 1,732 | Upgrade
|
| Operating Cash Flow Growth | 194.16% | -39.46% | -26.46% | -29.67% | 64.29% | Upgrade
|
| Capital Expenditures | -260.2 | -252.4 | -253 | -244.6 | -325.8 | Upgrade
|
| Cash Acquisitions | - | -1,062 | -95.2 | - | - | Upgrade
|
| Divestitures | 42.5 | 3,927 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -30 | -13.3 | -20.2 | -4 | Upgrade
|
| Investment in Securities | -321.8 | -148.5 | 624.5 | 689.8 | -1,350 | Upgrade
|
| Other Investing Activities | -173.4 | -121.8 | -89.2 | -172.7 | -42.6 | Upgrade
|
| Investing Cash Flow | -712.9 | 2,313 | 173.8 | 252.3 | -1,723 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 5.2 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -7 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -1.8 | Upgrade
|
| Issuance of Common Stock | 174.1 | 179.5 | 169.9 | 146.4 | 158.6 | Upgrade
|
| Repurchase of Common Stock | -893.4 | -1,159 | -879.6 | -1,727 | -512.8 | Upgrade
|
| Other Financing Activities | -237.5 | -3.1 | -1.3 | -3.8 | -0.3 | Upgrade
|
| Financing Cash Flow | -956.8 | -983 | -711 | -1,585 | -356.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | -44.8 | 38.6 | 16.8 | 19.2 | 13.9 | Upgrade
|
| Net Cash Flow | -119.3 | 1,911 | 375.4 | -94.8 | -332.8 | Upgrade
|
| Free Cash Flow | 1,335 | 289.9 | 642.8 | 973.6 | 1,406 | Upgrade
|
| Free Cash Flow Growth | 360.50% | -54.90% | -33.98% | -30.77% | 117.26% | Upgrade
|
| Free Cash Flow Margin | 22.00% | 5.33% | 12.83% | 21.81% | 26.88% | Upgrade
|
| Free Cash Flow Per Share | 2.28 | 0.48 | 1.05 | 1.56 | 2.23 | Upgrade
|
| Cash Interest Paid | 20.2 | 19.6 | 19.9 | 19.3 | 20.2 | Upgrade
|
| Cash Income Tax Paid | 490.4 | 1,166 | 444.9 | 466.7 | 182.5 | Upgrade
|
| Levered Free Cash Flow | 1,170 | 1,339 | 566.93 | 776.73 | 1,009 | Upgrade
|
| Unlevered Free Cash Flow | 1,182 | 1,351 | 577.93 | 788.73 | 1,020 | Upgrade
|
| Change in Working Capital | 154.6 | -259.3 | -526.3 | -421.4 | 145.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.